As high-deductible health plans and rising out-of-pocket costs shift more financial responsibility to patients, healthcare providers are facing a growing challenge: getting paid. Payment ...
It’s well-known that women are often misdiagnosed and mistreated. At the same time, physicians are dealing with major burnout. More than 45% of physicians reported at least one symptom ...
The team that steered a clinical-stage cancer drug to an acquisition by Eli Lilly is back at it again, unveiling a new venture supported by $177 million for a pipeline of precision ...
Each year, cybersecurity researchers discover more common vulnerabilities and exposures (CVEs) than there are types of the common cold. For reference, there are about 200 types of the ...
In a recent webinar hosted by MedCity News and sponsored by business banking provider* Mercury, venture capitalists shared their perspectives on health tech, medtech and biopharma sector ...
For people who are completely blind from myriad causes – genetic diseases, age-related conditions, accidents, combat injuries – the question often arises: Can’t I just get a new eye? ...
A Merck drug developed to prevent disease from respiratory syncytial virus (RSV) in infants has won FDA approval, introducing competition to products already available from Pfizer and ...
GoodRx, a prescription savings company, launched a new offering on Monday that delivers a cost-plus pricing model for independent pharmacies. Santa Monica, California-based GoodRx ...
The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu viruses is the latest blow to national defense, former health ...
First Responders are often the first to witness signs of an emerging health crisis — an unusual number of overdoses in one neighborhood, a surge in heat-related illness, or a wave of ...
Amid an escalating overdose crisis, growing attention has turned to racial and ethnic disparities in the accessibility of medication-assisted treatment (MAT), such as buprenorphine. Most ...
There have been several recent efforts to crack down on pharmacy benefit managers, from bills in Congress to an investigation by the Federal Trade Commission. But the state of ...